| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4003153 | American Journal of Ophthalmology | 2011 | 8 Pages |
Abstract
No positive effect of systemic CsA administration for suppressing rejection in high-risk corneal transplantation was observed. With a relatively high incidence of systemic side effects, the results suggest that this protocol should not be recommended for corneal transplant recipients, especially those of advanced age.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Jun Shimazaki, Seika Den, Masahiro Omoto, Yoshiyuki Satake, Shigeto Shimmura, Kazuo Tsubota,